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Abstract
Magnesium (Mg), also known as “the forgotten electrolyte”, is the 
fourth most abundant cation overall and the second most abundant 
intracellular cation in the body. Mg deficiency has been implicated in 
the pathophysiology of many diseases. This article is a review of the 
literature regarding Mg abnormalities with emphasis on the implica-
tions of hypomagnesemia in critical illness and on treatment options 
for hypomagnesemia in critically ill patients with sepsis. Hypomagne-
semia is common in critically ill patients, and there is strong, consist-
ent clinical evidence, largely from observational studies, showing that 
hypomagnesemia is significantly associated with increased need for 
mechanical ventilation, prolonged ICU stay and increased mortality. 
Although the mechanism linking hypomagnesemia with poor clinical 
outcomes is not known, experimental data suggest mechanisms con-
tributing to such outcomes. However, at the present time, there is no 
clear evidence that magnesium supplementation improves outcomes 
in critically ill patients with hypomagnesemia. Large, well-designed 
clinical trials are needed to evaluate the role of magnesium therapy 
for improving outcomes in critically ill patients with sepsis.
Keywords: Magnesium; Hypomagnesemia; Sepsis; Critical illness; 
Mortality
Introduction
Magnesium (Mg), the fourth most abundant cation overall 
and second most abundant intracellular cation in the human 
body, is an essential element of life: Mg deficiency induces 
a systemic stress response through activation of neuroendo-
crine pathways [1], has been implicated in the pathophysiol-
ogy of many diseases, and has been associated with increased 
mortality in ICU patients [2]. Some authors have called Mg 
“the forgotten electrolyte” [3, 4], because, although Mg al-
terations are common, hypomagnesemia is an important but 
underdiagnosed electrolyte abnormality. This article is a re-
view of the literature regarding Mg abnormalities with em-
phasis on the implications of hypomagnesemia and on treat-
ment options for hypomagnesemia in critically ill patients 
with sepsis.
Literature Search Methods
We conducted a literature search in MEDLINE database (Jan-
uary 1980 to March 2015), the Cochrane Central Register of 
Controlled Trials (fourth quarter, 2014) and Embase (January 
1980 to December 2014), using the terms “magnesium”, “sep-
sis”, “hypomagnesemia” and “critically ill”. All identified 
manuscripts, including reviews, case series and case reports 
were evaluated for relevance, and only articles deemed perti-
nent, current, and representative were included in this review. 
Reference lists in all these manuscripts were also assessed, 
in an attempt to identify additional relevant references. The 
quality of the studies was assessed using the following crite-
ria. 1) Was the trial prospective? 2) Was the trial randomized? 
3) Was the trial controlled? 4) Was the patient number ac-
ceptable, and was the role of Mg the primary outcome of the 
study? 5) Does the study clearly define cutoff points for hy-
pomagnesemia, normomagnesemia and hypermagnesemia? 
6) Are there clearly defined patient inclusion and exclusion 
criteria? 7) Does the study describe basic patient characteri-
stics?
Two authors (DV and MK) assessed quality of the stud-
ies using the above criteria and differences of opinion were 
resolved by discussion with participation of the other three 
authors as well. Letters and case reports were not included in 
the quality assessment. With regard to studies published in lan-
guages other than English, we chose to include studies in other 
languages if they were accompanied by detailed abstract that 
allowed us to understand the results.
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Literature Search Results
The literature search, as described above, yielded 383 articles 
for initial consideration. All articles were entered into a Refer-
ence Manager v. 12 database. Of the 383 initially identified 
articles, 181 articles were found to be relevant to this review. 
The full text of these articles, case series, case reports, and let-
ters were retrieved and examined. Finally 20 clinical studies, 
11 experimental or laboratory studies and seven reviews were 
included in this manuscript.
Many studies show high prevalence of hypomagnesemia 
in critically ill ICU patients, and hypomagnesemia has been 
associated with sepsis and increased mortality in critically ill 
sepsis patients.
An observational study on 102 medical ICU patients by 
Reinhart et al showed that hypomagnesemia was present in 
20% of patients, while hypermagnesemia was present in 9% 
of patients, and, of all ions, Mg had the highest prevalence of 
abnormal values [5]. Another prospective observational study 
on 100 ICU patients by Limaye et al showed that, on ICU ad-
mission, 52% of patients had hypomagnesemia, 41% had nor-
mal serum Mg levels and 7% had hypermagnesemia. In this 
study, patients with hypomagnesemia had more frequent need 
for mechanical ventilator support (73% (38 of 52) vs. 53% (22 
of 41), P < 0.05), longer duration of mechanical ventilation 
(4.27 ± 5.01 days vs. 2.15 ± 3.36 days, P < 0.05), increased 
incidence of sepsis (38% (20 of 52 patients) vs. 19% (eight of 
41 patients), P < 0.05) and higher mortality (57.7% (30 of 52 
patients) vs. 31.7% (13 of 41 patients), P < 0.05) compared to 
patients with normal Mg levels [6].
Another prospective observational study by Soliman et al 
measured ionized Mg levels on 446 patients admitted to a uni-
versity hospital ICU over 3 months and showed that on admis-
sion to ICU, 18% of patients had ionized hypomagnesemia, 
14% had ionized hypermagnesemia and 68% had normal ion-
ized Mg levels, but there was no association between ionized 
Mg levels on admission and length of stay or mortality. How-
ever, patients who developed ionized hypomagnesemia during 
ICU stay had significantly higher prevalence of septic shock 
(57% vs. 11%, P < 0.01), longer ICU stay (15.4 ± 15.5 days vs. 
2.8 ± 4.7 days, P < 0.01) and higher mortality (35% vs. 12%, 
P < 0.01). Development of ionized hypomagnesemia was as-
sociated with diuretic use, development of sepsis and worse 
outcomes, and the authors concluded that monitoring of ion-
ized Mg levels may have prognostic and therapeutic implica-
tions [7].
Similarly, two more recent large studies from India and 
China also showed association between hypomagnesemia and 
outcome. A prospective observational study on 601 medical 
ICU (MICU) patients showed that 25% of patients had hy-
pomagnesemia on admission. Hypomagnesemia was associ-
ated with longer MICU stay (5.46 ± 5.75 days vs. 3.93 ± 3.88 
days, P = 0.0002), need for mechanical ventilation (56.86% 
vs. 24.33% P<0.0001) and mortality (38.56% vs. 14.73% P 
< 0.0001), but was not associated with duration of mechani-
cal ventilation [8]. Another prospective observational study on 
374 critically ill patients showed that hypomagnesemia was 
present in 102 patients (27.27%). Patients with hypomagne-
semia did not differ from patients with normomagnesemia or 
hypermagnesemia with regard to APACHE scores, age, sex, 
or other electrolyte abnormalities. However, hypomagnesemia 
was associated with longer ICU stay (15.98 ± 13.29 days vs. 
12.43 ± 7.14 days, P = 0.034), higher SOFA scores (6.86 ± 
3.12 vs. 5.46 ± 2.75, P = 0.004), and higher mortality (54.90% 
vs. 33.88%, P = 0.010). Logistic regression showed that, in 
this study, serum Mg level was an independent risk factor for 
mortality (odds ratio (OR): 2.163, 95% CI: 1.015 - 4.610, P = 
0.046). Of note, this study was published in Chinese language, 
but was accompanied by a detailed abstract in English, which 
allowed us to understand the results [9].
Cojocaru et al assessed sepsis patients and found a signifi-
cant decrease of Mg serum concentrations (1.26 ± 0.12 mEq/L 
vs. 1.69 ± 0.14 mEq/L, P < 0.001) in patients with acute bac-
terial infections (bronchopneumonia and urinary tract infec-
tions). These changes of Mg concentration occurred within 
days, persisted for several weeks, were independent of the 
bacteria causing the infection, and did not show correlation 
with disease severity. The authors concluded that measurement 
of serum Mg levels is useful in bacterial infections; therefore, 
physicians should maintain a high index of suspicion for diag-
nosis and treatment of hypomagnesemia [10].
A retrospective study by Safavi evaluated serum Mg lev-
els on admission to the ICU in 100 patients, and showed that 
patients who developed hypomagnesemia during ICU stay had 
higher APACHE and SOFA scores on admission, higher maxi-
mum SOFA score during ICU stay, greater need for ventilator 
support and higher mortality. The study concluded that moni-
toring of serum Mg levels may have therapeutic and prognos-
tic implications [11].
A prospective observational study by Santos et al in 
2010 evaluated 54 AIDS patients who developed acute kid-
ney injury (AKI) during hospitalization. In this study, ICU 
admission, sepsis, dialysis and hypomagnesemia were associ-
ated with non-recovery of renal function and with mortality. 
Hypomagnesemia was the only factor associated with both 
non-recovery of kidney function (OR: 6.945, 95% CI: 1.207 
- 39.958, P = 0.03) and with death (OR: 6.923, 95% CI: 1.174 
- 40.807, P = 0.033) in multivariate logistic regression, but it 
is not clear if hypomagnesemia is a determinant or simply a 
marker of illness severity in AIDS patients [12]. Similarly, an 
observational study by Alves et al evaluated 232 ICU patients 
and showed that although the prevalence of hypomagnesemia 
was similar in patients with or without AKI, hypomagnesemia 
was an independent risk factor for non-recovery of renal func-
tion [13].
Chernow et al measured serum Mg levels in blood sam-
ples from 193 ICU patients and found that 117 of 193 (61%) 
had hypomagnesemia on ICU admission. In this study, patients 
with severe hypomagnesemia (defined as serum Mg ≤ 1.0 
mEq/dL) had more hypokalemia, received aminoglycosides 
more often and had higher mortality compared to similarly ill 
patients with normal Mg levels. Because severe hypomagne-
semia was associated with aminoglycoside therapy and with 
increased mortality, these authors recommended measurement 
of Mg levels in ICU patients receiving aminoglycosides, and 
Mg replacement therapy in patients with serum Mg values ≤ 
1.0 mEq/dL [14].
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Dabbagh et al published in 2006 the results of a prospec-
tive observational study on 71 patients consecutively admitted 
to the ICU, and showed that 41 of 71 patients (60%) had hy-
pomagnesemia. Univariate analyses showed that APACHE II 
scores, arrhythmias, duration of mechanical ventilation, ICU 
length of stay and mortality were significantly lower in pa-
tients who received Mg supplementation at dose > 1 g/day, 
compared to patients who received less than 1 g/day. However, 
because multivariate analysis showed that only APACHE II 
score was an independent risk factor for mortality, the authors 
questioned whether the observed association between Mg sup-
plementation and mortality could be related to illness severity. 
In addition, because daily Mg supplementation > 1 g/day is 
potentially associated with lower mortality, the authors sug-
gested an aggressive ICU Mg supplementation protocol [15].
A prospective, cohort study on 144 ICU patients over a 
6-month period by Escuela et al evaluated the association of 
total serum magnesium (tsMg) and ionized serum magnesium 
(Mg2+) alterations with outcome. This study showed that Mg 
alterations are frequently found in ICU patients, and the agree-
ment between tsMg and ionized Mg2+ levels on admission and 
on the second, third and last ICU day is very weak (k = 0.076, 
-0.02, 0.16, and -0.17, respectively). Ionized hypermagnesem-
ia was associated with higher mortality, but there was no as-
sociation between hypomagnesemia and mortality [16].
Guerin et al published in 1996 the findings of a prospective 
study evaluating 179 consecutive ICU patients over a 4-month 
period. tsMg and erythrocyte Mg (Mge) were measured by 
atomic absorption spectrophotometry. This study showed 
high prevalence of Mg abnormalities: 79 patients (44%) had 
hypomagnesemia and 10 (6%) had hypermagnesemia on ICU 
admission. High Mg levels were associated with increased 
mortality, whereas there was no association between low Mgs 
and Mge levels and mortality [17].
Huijgen et al published in 2000 a study evaluating the 
relationship between ionized Mg, total Mg, and serum albu-
min levels, and the role of extracellular and intracellular Mg 
in outcome prediction in 115 ICU patients. This study showed 
significantly negative correlation between serum albumin and 
ionized Mg. There was no correlation between low extracel-
lular or intracellular Mg and clinical outcome. The authors 
pointed out that observation of hypomagnesemia in critically 
ill patients depends on the Mg fraction measured, and reliable 
serum ionized Mg concentrations can only be obtained by di-
rect measurement, rather than by calculation from serum total 
Mg and albumin. They also suggested that the absence of cor-
relation with clinical outcome shows that hypomagnesemia is 
merely an epiphenomenon [18].
A retrospective study by Moskowitz et al reviewed 8,922 
patients admitted to a 77-bed ICU over 8 years and evaluated 
the association between Mg deficiency and lactic acidosis. In 
this study, hypomagnesemia was present in 22.6% of patients, 
and was associated with lactic acidosis. The authors suggested 
that low plasma Mg level is a correctable risk factor for lactic 
acidosis in critical illness [19].
A prospective observational study by Rubeiz et al on 381 
acutely ill patients showed that, although hypomagnesemic 
and normomagnesemic patients had comparable APACHE II 
scores and did not differ with regard to other clinically relevant 
variables, patients with hypomagnesemia in the ICU and in the 
wards had mortality approximately twice as high compared to 
patients with normal Mg levels (P < 0.01) [20].
Zafar et al published in 2014 the results of a single-center 
prospective observational study in 70 ICU patients with normal 
vs. low plasma Mg levels, and showed that hypomagnesemia 
was associated with significantly higher mortality (74.7% vs. 
36%, P = 0.004) [2].
With regard to Mg level measurement, as 99% of Mg is 
located inside cells, intracellular ionized Mg concentration 
(iMg) may be physiologically more relevant. Therefore, meas-
urement of iMg in erythrocytes (iMge) can provide relevant 
information on Mg status. A study by Arnold et al used a Mg 
loading test to diagnose Mg depletion in ICU patients, and 
showed that Mg levels in plasma, red blood cells and mononu-
clear blood cells did not differ significantly between patients 
with vs. patients without Mg depletion. This study concluded 
that normal plasma, red blood cell and mononuclear blood cell 
Mg concentration cannot exclude Mg depletion in critically ill 
patients [21].
A study by Malon et al in critically ill postoperative pa-
tients used ion-selective electrode to measure erythrocyte and 
serum iMg concentration, and atomic absorption spectrometry 
to measure total magnesium concentration (tMg). The authors 
concluded that measurement of intracellular Mg concentration 
is the preferred method for evaluating Mg status, and iMge is 
the most relevant parameter for diagnosing hypomagnesemia 
or hypermagnesemia [22].
Similarly, a study by Johansson evaluated Mg serum 
levels in blood from healthy volunteers and critically ill pa-
tients and showed weak correlation of free ionized magnesium 
(iMg2+) and total Mg in critically ill patients. This study con-
cluded that, in contrast to routine clinical practice, where most 
clinical laboratories only measure total Mg, measurement of 
free ionized magnesium (iMg2+) is the most useful test for es-
timating Mg status [23].
Findings of all the above clinical studies are summarized 
in Table 1 [2, 5-21, 24, 25]. Because these studies are hetero-
geneous with regard to patient population and study design, we 
did not attempt quantitative synthesis of the data.
With regard to experimental data, studies in rats with en-
dotoxic shock showed that hepatic Mg2+ content was signifi-
cantly lower in septic rats compared to non-septic controls. 
Treatment of endotoxic rats with diltiazem, a calcium antago-
nist, restored hepatic cellular Mg2+ to normal levels [26]. An-
other study by Lee in rats with endotoxemia showed that Mg 
administration mitigates in a dose-dependent manner oxida-
tive stress, inflammatory response and acute lung injury, with 
possible mechanisms being antagonism of the L-type calcium 
channels and of the N-methyl-D-aspartate (NMDA) receptor 
[27].
A randomized experimental study by Esen et al on a rat 
model of intraperitoneal sepsis (126 male Sprague-Dawley 
rats) showed that use of magnesium sulfate correlated with 
protective effect on blood brain barrier integrity, as Mg at-
tenuated the increased permeability of the barrier, leading to 
reduced formation of brain edema [28].
In another multi-experimental study on a total of 299 rats, 
Salem et al showed that Mg deficiency was strongly associ-
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Table 1.  Clinical Studies on Hypomagnesemia in Critically Ill Patients











Magnesium loading test, 20  
ICU patients
Normal Mg concentrations in plasma, red blood cell or mononuclear  
blood cell cannot exclude magnesium depletion.
Chen et al [9] Hangzhou, 
China, 2015
Single-center prospective 
observational study, 374 ICU  
patients
Hypomagnesemia in 102 patients (27.27%), associated with higher 
SOFA scores, longer ICU stay and higher mortality 54.90% vs. 33.88%, 





Observational study, 193 
postoperative ICU patients
Sixty-one percent of patients had hypomagnesemia on ICU admission. 
Severe hypomagnesemia (serum Mg ≤ 1.0 mEq/dL) associated 





Observational study 53 
patients with acute stroke and  
acute infection
Hypomagnesemia in patients with acute bacterial infections occurred 






study, 71 ICU patients
Forty-one of 71 patients (60%) had hypomagnesemia. Daily Mg 






study, 144 ICU patients
Hypomagnesemia in 52.5% of patients on ICU admission ionized 
hypermagnesemia associated with higher mortality. No association  





Prospective study, 32 ICU  
patients
Three of 32 patients (9.4%) had low serum Mg (≤ 0.7 mmol/L) but 
normal muscle Mg. Fifteen of 32 patients (47%) had low muscle Mg but 






study, 179 ICU patients
On ICU admission, hypomagnesemia in 79 (44%) patients, 
hypermagnesemia in 10 (6%). High Mg level associated with higher 






Prospective multicenter study,  
115 ICU patients
Negative correlation between serum albumin and ionized magnesium. 







study over 1-year, 601 ICU  
patients
Hypomagnesemia in 25% of patients, associated with greater need for 







study, 100 ICU patients
Hypomagnesemia associated with mechanical ventilation need (P < 
0.05), and duration (P < 0.05), increased incidence of sepsis (38% vs. 





Retrospective study, 8,922 
ICU patients over 8 years






Observational study, 102 
medical ICU patients
Hypomagnesemia in 20% of patients, hypermagnesemia in 9% of 






study, 381 consecutive acutely  
ill patients
Patients with hypomagnesemia had comparable APACHE II scores but 






Observational study, 94 
consecutive ICU patients






Retrospective study, 100 ICU  
patients
Development of hypomagnesemia in ICU associated with higher SOFA  
scores, need for ventilator support and mortality.




Fifty-four hospitalized AIDS 
patients with acute kidney  
injury








Patients who developed hypomagnesemia during ICU stay had higher 
prevalence of sepsis, septic shock, longer ICU stay and higher mortality.
Zafar et al [2] New Delhi, 
India, 2014
Prospective observational 
study, 70 ICU patients
Hypomagnesemia present in 24.29% of ICU patients, associated with  
higher mortality (74.7% vs. 36%, P = 0.004).
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ated with increased mortality and that Mg replacement pro-
vided significant protection from endotoxin challenge. This 
study also concluded that cellular injury in sepsis is associated 
with circulating Mg concentration abnormalities [29]. Finally, 
microvascular blood flow alterations are important in patients 
with sepsis. Data from an open label experimental study on 14 
ICU patients published by Pranskunas et al suggested that Mg 
treatment did not improve microcirculation in sepsis [30].
A study by Liu showed that Mg deficiency in sepsis pa-
tients promoted the translocation of high mobility group box 
1 (HMGB1), an important inflammatory factor that is closely 
related to mortality, from the nucleus to the cytoplasm and its 
extracellular secretion in LPS-activated macrophages, while 
enhancing the expression of HMGB1 mRNA. Furthermore, 
Mg deficiency promoted the translocation of NF-kappaB from 
the cytoplasm to the nucleus in LPS-activated macrophages. 
Mg deficiency also activates the NF-kappaB signaling path-
way [31].
A review by Harkema published in 1992 evaluated the 
benefits of adenosine triphosphate/magnesium chloride (ATP-
MgCl2) as energy source and vasodilator in experimental is-
chemia, shock and sepsis, and concluded that ATP-MgCl2 im-
proved cellular function, organ function and survival [32].
Results of the above laboratory or experimental studies 
are summarized in Table 2 [22, 23, 26-31, 33-35].
Discussion
Mg, a very important intracellular cation which activates en-
zyme systems involved in energy metabolism, is required for 
nucleic acid transcription, messenger RNA translation and 
protein synthesis, and is responsible for regulation of mito-
chondrial function. In addition, Mg ions have important role 
in immunological functions, including macrophage activa-
tion, adherence and bactericidal activity of granulocyte oxi-
dative burst, lymphocyte proliferation and endotoxin binding 
to monocytes. In addition, increased cytokine concentration 
has been recorded in experimental Mg deficiency inflamma-
tory models [34]. Therefore, the critical role of Mg in sepsis 
Table 2.  Experimental and Laboratory Studies Evaluating Magnesium in Critical Illness
Author Origin/year Study design Findings
Esen et al [28] Istanbul, 
Turkey, 2005
Randomized experimental 
study, intraperitoneal sepsis 
model, 126 male rats
Magnesium attenuated the increased blood brain barrier permeability  






Experimental study in baboons 
receiving adrenaline infusion
Mg infusion abolished arrhythmias, increased CO and SV and reduced 





Blood samples from 40 
healthy volunteers and 46  
patients
Weak correlation between free ionized magnesium (iMg2+) and total Mg 
in critical illness. Free ionized magnesium (iMg2+) is most useful for  
estimating Mg status
Lee et al [27] Taipei, Taiwan, 
2011
Ninety-six adult male rats In endotoxemia, MgSO4 mitigates oxidative stress, acute lung injury,  
likely via calcium channel and NMDA antagonism
Liu et al [31] Shanghai, 
China, 2013
Murine macrophage cells in 
normal or low magnesium
Magnesium deficiency promotes HMGB1 nucleus to cytoplasm 






Sixty-nine ICU patients, 
measured erythrocyte and 
serum iMg, and total  
magnesium (tMg)
Intracellular Mg concentration preferred for Mg status evaluation. iMge  






Male Wistar rat inflammatory  
model






Single-center open label study, 
14 ICU patients






Randomized controlled studies 
- endotoxin challenge on 299  
rats
Mg deficiency strongly associated with mortality. Mg replacement 






Endotoxic shock in 
hypovolemic rats
Hepatic Mg content lower in endotoxic rats. Diltiazem treatment before  





Experiment on male ICR mice Significantly reduced cardiac tolerance to hypoxia in Mg deficiency
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could be attributed to its immune system effects, which are 
important in the pathogenesis of sepsis. Furthermore, Mg has a 
fundamental role in regulation of cardiovascular homeostasis: 
Experimental data on male ICR mice published by Watanabe 
et al show significantly reduced cardiac tolerance to hypoxia in 
animals with Mg deficiency [35], while small changes of free 
Mg in cardiac and vascular muscle membranes can produce 
significant effects on the mechanical and electrical activities 
of these cells [36].
Of interest, Mg++ deficiency in the environment has been 
implicated in development of toxic shock syndrome by strains 
of Staphylococcus aureus. The hypothesis is that fibers in tam-
pons combine with Mg++, thereby producing Mg++ deficient 
environment, where growth of staphylococci is slower com-
pared to ordinary culture media, and therefore maximal toxin 
production is allowed to occur. As absorbency of tampons cor-
relates with capacity to absorb Mg++, it is possible to pro-
duce safer tampons, in which Mg content is regulated, so that 
staphylococci do not grow in a Mg-deficient environment [37].
Fluid and electrolyte abnormalities are among the most 
common abnormalities seen in ICU patients with sepsis. Usual 
mechanisms involved in the pathogenesis of electrolyte disor-
ders, including altered magnesium levels, are reduced kidney 
perfusion due to hypovolemia and hypotension, heart failure 
due to sepsis-related fluid and electrolyte abnormalities, ac-
tivation of the vasopressin and renin-angiotensin-aldoster-
one system, inappropriate fluid administration and effects of 
medications. Low serum Mg levels are frequently identified 
in ICU patients with sepsis [38], and have been implicated in 
development of systemic inflammatory response syndrome 
(SIRS) and organ dysfunction. Mg depletion is also associ-
ated with electrolyte abnormalities, including hypocalcemia, 
hypophosphatemia and hypokalemia [39], and correlates with 
neuromuscular abnormalities, including hyperexcitability and 
respiratory muscle weakness [40]. Hypomagnesemia predis-
poses the myocardium to reperfusion injury by depleting en-
dogenous antioxidants and recruiting inflammatory cells. Vita-
min E supplements could prevent this injury, possibly through 
restoration of endogenous antioxidant defenses, as shown in a 
study by Weglicki et al [41]. Mg also acts as natural calcium 
antagonist by regulating calcium access into the cell. For all 
these reasons, Mg deficit in critically ill sepsis patients is re-
lated to poor outcome, therefore recognition and treatment of 
hypomagnesemia is of great importance, and critical care clini-
cians have great interest in hypomagnesemia assessment and 
treatment [42].
Hypomagnesemia is frequently observed in critically ill 
patients, with prevalence as high as 50% [16, 25]. Several ex-
perimental and clinical studies show that hypomagnesemia 
correlates with sepsis, while sepsis is recognized as independ-
ent factor for development of hypomagnesemia [43]. Micro-
circulatory alterations have critical role in sepsis and persist 
despite correction of systemic hemodynamic parameters. Mg 
is involved in both endothelium-dependent and non-endothe-
lium-dependent vasodilatory pathways. Pranskunas et al de-
scribed sublingual microcirculatory alterations in patients with 
severe sepsis and septic shock and showed that microcircula-
tory variables and perfusion did not improve after infusion of 
a fixed, limited Mg sulfate dose [30]. As cell membrane cal-
cium channels are Mg dependent and Mg seems to be a fac-
tor regulating sepsis-associated calcium entry, Mg is strongly 
correlated with calcium ion entry in septic shock. Experimen-
tal data published by White suggest that when isolated myo-
cytes are exposed to different Mg concentrations, lower Mg 
concentrations are associated with efflux of free calcium from 
the sarcoplasmic reticulum into the cytosol. Similarly, experi-
ments in animal sepsis models show that intracellular calcium 
is increased during hypomagnesemia. Finally, experiments in 
a Mg deficient sepsis rat model have shown that intracellular 
calcium may cause activation of calcium sensitive nitric oxide 
synthase (NOS) in septic shock [44].
Mg level assessment is difficult, because Mg is mostly 
intracellular and there is no simple method to measure total 
body Mg. Because Mg is primarily a cofactor in intracellu-
lar biochemical reactions, and almost 99% of total body Mg 
is intracellular, the practice of measuring Mg in blood serum 
alone has been questioned, and methods for measurement of 
total cellular Mg in erythrocytes (tMge) have been developed. 
However, intracellular ionized Mg concentration is physiolog-
ically much more relevant [22], and the question of whether 
ionized Mg should be measured in clinical practice has been 
raised [45].
Different studies have shown that, depending on the popu-
lation studied and tMgs threshold value chosen, the incidence 
of hypomagnesemia ranges from 9.4% in critically ill COPD 
patients to 61% in postoperative ICU patients [14, 24]. The 
high prevalence of hypomagnesemia, based on tMgs can prob-
ably be explained by Mg shift from extracellular to intracel-
lular compartments, whereby iMg2+s concentration can remain 
unchanged, in contrast with tMgs. Because more than 99% 
of body Mg is intracellular, intracellular Mg concentration 
changes due to Mg shift from extracellular to intracellular fluid 
may remain undetectable. A study by Huijgen et al confirms 
that hypomagnesemia is common in critically ill patients when 
tMgs is measured, but 70% of these patients no longer have 
hypomagnesemia when ionized magnesium (iMg2+) is meas-
ured. This finding suggests that in clinical conditions (like 
sepsis) where abnormal albumin and protein concentrations 
are expected, iMg2+ measurement is preferred to tMgs meas-
urement. However, studies still report results based on serum 
tMgs measurements. Chernow et al reported that postoperative 
ICU patients with severe hypomagnesemia (< 1.2 mg/dL (<0.5 
mmol/L)) had higher mortality compared to patients without 
hypomagnesemia (P < 0.02), despite similar illness severity 
scores in both populations. Similarly, in a study by Rubeiz et 
al, although APACHE II scores were similar in ICU patients 
with hypomagnesemia vs. patients without, mortality was sig-
nificantly higher in patients with hypomagnesemia [20].
Hypomagnesemia can be treated with parenteral Mg ad-
ministration, guided by serum Mg level, targeting Mg levels > 
1.5 mg/dL. Mg infusion is generally well tolerated, as Mg has 
antiarrhythmic effects and increases cardiac output and stroke 
volume, while slightly reducing peripheral vascular resistance 
[33]. However, because Mg inhibits platelet function, caution 
is needed in patients with impaired platelet function or other 
bleeding disorders [46]. Aim of Mg therapy is to resolve symp-
toms related to hypomagnesemia, while avoiding hyperma-
gnesemia. Parenteral Mg supplementation is indicated if Mg 
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concentration is < 0.5 mmol/L (plasma (Mg2+) < 1 mg/dL) or 
in the presence of hypomagnesemia-related symptoms (elec-
trocardiographic changes, life-threatening arrhythmias includ-
ing torsades de pointes, seizures, and coma). Infusion time is 
important, because Mg has slow distribution into the tissues 
and is rapidly eliminated by renal excretion, with up to 50% 
of infused Mg excreted in the urine. Severe hypomagnesemia 
requires treatment with Mg doses up to 1.5 mEq/kg. Regard-
ing rate of administration, doses < 6 g magnesium sulfate are 
infused over 8 - 12 h, whereas higher doses are infused over 24 
h. To prevent hypermagnesemia, Mg dosage should be reduced 
in patients with renal impairment. In patients with deficient 
diet or malabsorption and Mg concentrations 0.5 - 0.7 mmol/L, 
prolonged therapy with enteral or parenteral nutrition support 
is sometimes necessary [38, 42, 47].
Conclusion
Hypomagnesemia is common in sepsis patients, both in the 
ICU and in the wards. In order to provide optimal care, ICU 
clinicians should be familiar with the principles and practice 
of fluid and electrolyte pathophysiology. Hypomagnesemia 
should be identified and corrected, because it is associated 
with increased adverse events and higher mortality in critically 
ill patients. Total or ionized serum Mg measurement is use-
ful in sepsis patients, and physicians should maintain a high 
index of suspicion for hypomagnesemia and the need for Mg 
replacement therapy.
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